FLASH NEWS LIVE

Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025

Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025

Tokyo, Japan and Cambridge, UK, 13 February 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the fourth quarter and 12 months ended 31 December 2025. The f…

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp